← Leaderboards
Dana Elise Rollison
H. Lee Moffitt Cancer Ctr & Res Inst
$6,546,802
Attributed
$7,275,305
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,275,305 · 4
By mechanism
R01$4,286,681 · 2
P50$1,531,618 · 1
U01$1,457,006 · 1
Top collaborators
- Susan T Vadaparampil2 shared
Most similar at H. Lee Moffitt Cancer Ctr & Res Inst
Same institution · by research overlap
- John L. Cleveland$27,832,236
- Peter A Kanetsky$11,078,381
- Thomas H. Brandon$14,530,397
- Matthys Hendrik Botha$524,384
- Susan T Vadaparampil$11,375,059
Others in their field
Top investigators on “Diagnosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$590,717,255
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Richard K. Wilson · Washington University$297,645,172
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Carol Nesel · Westat$188,148,170
Research focus
DiagnosisParticipantMalignant NeoplasmsBaseTissuesProspective StudiesVirus DiseasesRisk FactorsTumorVirusPolyomavirus InfectionsSamplingTumor TissueMeasurementAntibodiesCase-Control StudiesEtiologyHuman Papilloma Virus InfectionDetectionMerkel CellsPapillomavirus InfectionsHuman PapillomavirusCutaneousHair Follicle Structure
Grant awards (15)
Advancing Clinical Trials: Working through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDERS)$722,373
U01 · FY2023 · CA
Advancing Clinical Trials: Working through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDERS)$734,633
U01 · FY2022 · CA
Prospective study of cutaneous viral infections and non-melanoma skin cancer$1,016,129
R01 · FY2018 · CA · contact PI
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo$313,329
P50 · FY2017 · CA · contact PI
Prospective study of cutaneous viral infections and non-melanoma skin cancer$308,387
R01 · FY2017 · CA · contact PI
Prospective study of cutaneous viral infections and non-melanoma skin cancer$673,547
R01 · FY2016 · CA · contact PI
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo$308,438
P50 · FY2016 · CA · contact PI
Prospective study of cutaneous viral infections and non-melanoma skin cancer$688,262
R01 · FY2015 · CA · contact PI
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo$299,359
P50 · FY2015 · CA · contact PI
Prospective study of cutaneous viral infections and non-melanoma skin cancer$695,218
R01 · FY2014 · CA · contact PI
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo$312,873
P50 · FY2014 · CA · contact PI
Prospective Study of the Associations between Cutaneous Papillomavirus and Polyo$297,619
P50 · FY2013 · CA · contact PI
Nested case-control study of JC virus infection and incident colorectal cancer$246,989
R01 · FY2008 · CA · contact PI
Nested case-control study of JC virus infection and incident colorectal cancer$323,888
R01 · FY2007 · CA · contact PI
Nested case-control study of JC virus infection and incident colorectal cancer$334,261
R01 · FY2006 · CA · contact PI